Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9718 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.902 |
High Similarity |
NPD7075 |
Discontinued |
0.9007 |
High Similarity |
NPD6801 |
Discontinued |
0.9 |
High Similarity |
NPD4380 |
Phase 2 |
0.8958 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8958 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8951 |
High Similarity |
NPD1510 |
Phase 2 |
0.8947 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8947 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8919 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8897 |
High Similarity |
NPD1549 |
Phase 2 |
0.8889 |
High Similarity |
NPD2796 |
Approved |
0.8889 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8868 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD1512 |
Approved |
0.8725 |
High Similarity |
NPD6799 |
Approved |
0.8693 |
High Similarity |
NPD7411 |
Suspended |
0.8671 |
High Similarity |
NPD1240 |
Approved |
0.8654 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD3817 |
Phase 2 |
0.8636 |
High Similarity |
NPD1934 |
Approved |
0.86 |
High Similarity |
NPD1511 |
Approved |
0.859 |
High Similarity |
NPD3882 |
Suspended |
0.8581 |
High Similarity |
NPD2801 |
Approved |
0.8581 |
High Similarity |
NPD7819 |
Suspended |
0.8562 |
High Similarity |
NPD6166 |
Phase 2 |
0.8562 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8552 |
High Similarity |
NPD1607 |
Approved |
0.8506 |
High Similarity |
NPD6599 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8415 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8375 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8301 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8291 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8278 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8267 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8194 |
Intermediate Similarity |
NPD920 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8151 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8065 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8036 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD919 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7947 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7943 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7853 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7797 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD2798 |
Approved |
0.775 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7687 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD943 |
Approved |
0.755 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7471 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7456 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7451 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD3267 |
Approved |
0.745 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD3225 |
Approved |
0.738 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7349 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD8313 |
Approved |
0.733 |
Intermediate Similarity |
NPD8312 |
Approved |
0.732 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7243 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7229 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6190 |
Approved |
0.72 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD37 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7179 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7179 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD17 |
Approved |
0.716 |
Intermediate Similarity |
NPD4965 |
Approved |
0.716 |
Intermediate Similarity |
NPD4966 |
Approved |
0.716 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7128
|
Intermediate Similarity |
NPD7698 |
Approved |